-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Neutral on Zymeworks, Raises Price Target to $13

Benzinga·03/10/2025 17:04:24
Listen to the news
HC Wainwright & Co. analyst Robert Burns maintains Zymeworks (NASDAQ:ZYME) with a Neutral and raises the price target from $12 to $13.